American Journal of Neuroradiology, Vol 13, Issue 6 1535-1543, Copyright © 1992 by American Society of Neuroradiology
ARTICLES |
MR proton spectroscopy in multiple sclerosis
RI Grossman, RE Lenkinski, KN Ramer, F Gonzalez-Scarano and JA Cohen
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia 19104.
PURPOSE: To elucidate the natural history of visualized MR abnormalities in patients with multiple sclerosis using proton spectroscopy. METHODS: MR imaging and proton spectroscopy (1H spectroscopy) were performed on 16 patients with clinically definite multiple sclerosis. All patients received gadopentetate dimeglumine (Gd- DTPA). RESULTS: Decreased levels of N-acetylaspartate (NAA) were demonstrated in 17 out of 21 lesions. No correlation was found between decreased NAA and Gd-DTPA enhancement. In five out of seven enhancing lesions, abnormal 1H spectra with extra peaks (termed marker peaks) at 2.1-2.6 ppm (ranging in absolute concentration from 10-50 mM protons) were observed. In nine out of 14 unenhancing lesions, no elevated marker peaks were observed. In the five other unenhancing lesions, the levels of these marker peaks were generally lower than the enhancing group. No correlation was found between the NAA levels and the levels of the marker peaks. We suggest two distinct biochemical processes: 1) decreased NAA reflecting neuronal cell loss, and 2) elevated marker peaks reflecting ongoing demyelination. CONCLUSIONS: Based upon these observations we infer that 1) the majority of enhancing lesions are demyelinating with extra peaks at 2.1-2.6 ppm representing a marker of this process, 2) enhancing lesions without this marker most likely represent edematous regions without significant demyelination, and 3) demyelination may be long in duration compared with transient blood- brain barrier disruption manifested by Gd-DTPA enhancement. Our results suggest that 1H spectroscopy has the ability to further categorize MR- demonstrated enhancing and unenhancing lesions in patients with multiple sclerosis and that it may be more sensitive than contrast enhancement in revealing the true time course of demyelination.
This article has been cited by other articles:
 |
|
 |
|
  A. Cianfoni, S. Niku, and S.G. Imbesi Metabolite Findings in Tumefactive Demyelinating Lesions Utilizing Short Echo Time Proton Magnetic Resonance Spectroscopy AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 272 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Boneschi, M. Rovaris, G. Comi, and M. Filippi The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials Multiple Sclerosis, August 1, 2004; 10(4): 341 - 347. [Abstract] [PDF]
|
|
|
|
 |
|
 W. C. W. Chu, K.-w. Chik, Y.-l. Chan, D. K. W. Yeung, D. J. Roebuck, R. G. Howard, C.-k. Li, and C. Metreweli White Matter and Cerebral Metabolite Changes in Children Undergoing Treatment for Acute Lymphoblastic Leukemia: Longitudinal Study with MR Imaging and 1H MR Spectroscopy Radiology, December 1, 2003; 229(3): 659 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J A Butteriss, A Ismail, D W Ellison, and D Birchall Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis Br. J. Radiol., September 1, 2003; 76(909): 662 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Saindane, S. Cha, M. Law, X. Xue, E. A. Knopp, and D. Zagzag Proton MR Spectroscopy of Tumefactive Demyelinating Lesions AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1378 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Garbern, D. A. Yool, G. J. Moore, I. B. Wilds, M. W. Faulk, M. Klugmann, K.-A. Nave, E. A. Sistermans, M. S. van der Knaap, T. D. Bird, et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation Brain, May 1, 2002; 125(3): 551 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Filippi and R. I. Grossman MRI techniques to monitor MS evolution: The present and the future Neurology, April 23, 2002; 58(8): 1147 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bonneville, D. M. Moriarty, B. S.Y. Li, J. S. Babb, R. I. Grossman, and O. Gonen Whole-Brain N-Acetylaspartate Concentration: Correlation with T2-Weighted Lesion Volume and Expanded Disability Status Scale Score in Cases of Relapsing-Remitting Multiple Sclerosis AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 371 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ge, R. I. Grossman, J. K. Udupa, J. S. Babb, D. L. Kolson, and J. C. McGowan Magnetization Transfer Ratio Histogram Analysis of Gray Matter in Relapsing-remitting Multiple Sclerosis AJNR Am. J. Neuroradiol., March 1, 2001; 22(3): 470 - 475. [Abstract] [Full Text]
|
|
|
|
|
|
I. Mader, W. Roser, L. Kappos, G. Hagberg, J. Seelig, E. W. Radue, and W. Steinbrich Serial Proton MR Spectroscopy of Contrast-enhancing Multiple Sclerosis Plaques: Absolute Metabolic Values over 2 Years during a Clinical Pharmacological Study AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1220 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Gonen, I. Catalaa, J. S. Babb, Y. Ge, L. J. Mannon, D. L. Kolson, and R. I. Grossman Total brain N-acetylaspartate: A new measure of disease load in MS Neurology, January 11, 2000; 54(1): 15 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Grossman BRAIN IMAGING AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 9 - 18. [Full Text] [PDF]
|
|
|
|
 |
|
 C A Davie, N C Silver, G J Barker, P S Tofts, A J Thompson, W I McDonald, and D H Miller Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 710 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. De Stefano, S. Narayanan, P. M. Matthews, G. S. Francis, J. P. Antel, and D. L. Arnold In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis Brain, October 1, 1999; 122(10): 1933 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pike, de Stefano, Narayanan, G. Francis, J. Antel, and D. Arnold Combined Magnetization Transfer and Proton Spectroscopic Imaging in the Assessment of Pathologic Brain Lesions in Multiple AJNR Am. J. Neuroradiol., May 1, 1999; 20(5): 829 - 837. [Abstract] [Full Text]
|
|